C4 Therapeutics
Biotechnology, 490 Arsenal Way Ste 120, Watertown, Massachusetts, 02472, United States, 51-200 Employees
Phone Number: 61********
Who is C4 THERAPEUTICS
C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generatio...
Read More
-
Headquarters: 490 Arsenal Way Ste 120, Watertown, Massachusetts, 02472, United States
-
Date Founded: 2016
-
Employees: 51-200
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 54 |
Show More
Does something look wrong? Fix it. | View contact records from C4 THERAPEUTICS
C4 Therapeutics Org Chart and Mapping
Email
Phone
Similar Companies to C4 Therapeutics
Arvinas
-
201-500
-
$ 100 Million to 250 Million
Beam Therapeutics
-
501-1000
-
$ 50 Million to 100 Million
Blueprint Medicines
-
501-1000
-
$ 100 Million to 250 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding C4 Therapeutics
Answer: C4 Therapeutics's headquarters are located at 490 Arsenal Way Ste 120, Watertown, Massachusetts, 02472, United States
Answer: C4 Therapeutics's phone number is 61********
Answer: C4 Therapeutics's official website is https://c4therapeutics.com
Answer: C4 Therapeutics's revenue is $10 Million to $25 Million
Answer: C4 Therapeutics's SIC: 2836
Answer: C4 Therapeutics's NAICS: 54
Answer: C4 Therapeutics has 51-200 employees
Answer: C4 Therapeutics is in Biotechnology
Answer: C4 Therapeutics top competitors include: Arvinas , Beam Therapeutics , Blueprint Medicines
Answer: C4 Therapeutics contact info: Phone number: 61******** Website: https://c4therapeutics.com
Answer: C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4Ts degrader medicines are designed to harness the bodys natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month